Paratek and partner Allergen held discussions last week regarding a potential deal, according to sources as reported by Betaville. The companies are currently working together on Omadacycline, a treatment for bacterial pneumonia and skin infections.
May 06, 2017 at 11:28AM
from
No comments:
Post a Comment